Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 1,920	$ 7,009
Investments - trading securities		2,569
Total Current Assets	1,920	9,578
Accrued Interest Receivable		182,125
Fixed assets - net		40,086
Installment Receivable	1,562,067
Total assets	1,563,987	3,820,398
Current Liabilities:
Accrued expenses		3,200
Other current liabilities	2,200
Total Current Liabilities	2,200	3,200
Long-Term Liabilities:
Notes payable	32,302	326,584
Line of credit
Total Long-Term Liabilities	32,302	326,584
Total Liabilities	34,502	329,784
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock, $.001 par value, 1,000,000 shares authorized, 1 issued and outstanding as at March 31, 2024 and December 31, 2023
Common Stock, $0.001 par value, 200,000,000 shares authorized, 182,370,497 issued and outstanding as at March 31, 2024 and December 31, 2023.	182,370	182,370
Additional paid in capital	19,206,627	19,206,627
Accumulated deficit	(17,859,512)	(15,898,383)
Total Stockholders’ Equity	1,529,485	3,490,614
Total Liabilities and Stockholders’ Equity	1,563,987	3,820,398
Nonrelated Party [Member]
Current Assets:
Investments - unrelated parties		30,000
Entrepreneurship Development [Member]
Current Assets:
Long term Notes Receivable - related parties		1,579,420
Related Party [Member]
Current Assets:
Long term Notes Receivable - related parties		1,815,676
Long term Investments - related parties		$ 163,513